Table 2 identifies the seven genes associated with hereditary myeloid malignancies, the associated malignancy, and potential congenital clinical features. Of these, the mutations in CEBPA manifest AML without progression from MDS, separating it from the otherwise difficult-to-segregate phenotypic features observed from mutations in all other associated genes. The gene discussed is CEBPA; the disease is acute myeloid leukemia.